Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. 1996

C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1360, USA.

Human immunodeficiency virus (HIV) disease is associated with loss of type 1 responses, including interleukin (IL)-12 production. The dramatic drop in p70 production seen at early stages of disease was found not to be associated with a similarly decreased p40 mRNA expression. p35 mRNA expression was more extensively reduced than p40 mRNA expression at these early stages. Monocytes infected in vitro with HIV displayed decreased p35 expression and p70 production, suggesting that such decreased IL-12 expression may contribute to reduced IL-12 production in HIV-positive patients' cells. In addition, treatment of cells with IL-10 increased IL-10 mRNA expression and decreased p40 expression in both HIV-positive and -negative cells, while neutralization of IL-10 increased p40 mRNA levels. These observations, together with the observed hyperproduction of IL-10 in HIV-positive patients, may explain the dysregulation of IL-12 production seen in HIV disease.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015967 Gene Expression Regulation, Viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Regulation of Gene Expression, Viral,Viral Gene Expression Regulation,Regulation, Gene Expression, Viral
D016753 Interleukin-10 A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein. IL-10,CSIF-10,Cytokine Synthesis Inhibitory Factor,IL10,Interleukin 10
D018664 Interleukin-12 A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS. Edodekin Alfa,IL-12,Natural Killer Cell Stimulatory Factor,Cytotoxic Lymphocyte Maturation Factor,IL 12,IL-12 p70,IL12,Interleukin 12,Interleukin-12 p70,Interleukin 12 p70

Related Publications

C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
April 1994, The Journal of experimental medicine,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
May 2000, The Journal of infectious diseases,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
April 1997, The Journal of infectious diseases,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
October 2004, Current HIV research,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
August 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
August 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
September 1996, The Journal of infectious diseases,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
September 1989, Clinics in laboratory medicine,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
April 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Chougnet, and T A Wynn, and M Clerici, and A L Landay, and H A Kessler, and J Rusnak, and G P Melcher, and A Sher, and G M Shearer
November 2006, Archives of internal medicine,
Copied contents to your clipboard!